Management of panic disorder in the elderly

被引:0
作者
Pace, Maxime [1 ]
Heckendorn, Mathilde [1 ]
Aouizerate, Bruno [2 ]
Hanon, Cecile [1 ]
Seigneurie, Anne-Sophie [1 ]
Lavaud, Pierre [1 ]
Hozer, Franz [1 ]
De Raykeer, Rachel Pascal [1 ]
Guerin-Langlois, Christophe [1 ]
Cormier, Lucile [1 ]
De Raucourt, Helene Poncelin [1 ]
Limosin, Frederic [1 ,3 ,4 ]
Hoertel, Nicolas [1 ,3 ,4 ]
机构
[1] AP HP Ctr Univ Paris, Ctr Ressource Reg Psychiat Sujet Age CRRPSA, Serv Psychiat & Addictol Adulte & Sujet Age, DMU Psychiat & Addictol, Paris, France
[2] Univ Bordeaux, Ctr Reference Reg Pathol Anxieuses & Depress, Ctr Expert Depress Resistante,Fdn FondaMentall,Po, CH Charles Perrens,Lab Nutr & Neurobiol Integree, Bordeaux, France
[3] Univ Paris, Inserm U1266, Inst Psychiat & Neurosci Paris, Paris, France
[4] Univ Paris, Fac Med Paris Descartes, Paris, France
来源
GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT | 2020年 / 18卷 / 03期
关键词
panic disorder; synthesis; treatment; antidepressants; elderly subject; GENERALIZED ANXIETY DISORDER; BEHAVIORAL-THERAPY; MENTAL-DISORDERS; OLDER-ADULTS; PLACEBO; EFFICACY; LIFE; MIRTAZAPINE; PREVALENCE; ALPRAZOLAM;
D O I
10.1684/pnv.2020.0878
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Panic disorder in the elderly is an understudied disorder, despite being associated with substantial functional impairment, diminished quality of life and increased suicide risk in this population. This disorder is likely to be underdiagnosed and sometimes inadequately treated in the absence of national and international guidelines for this vulnerable population. Few therapeutic trials have specifically focused on the efficacy and tolerability of pharmacologic and psychotherapy treatments for panic disorder in the elderly, and current approaches to detect and manage this disorder are mainly based on experts' opinion or extrapolation from data available in younger adults. This report aims to provide a summary of current knowledge on pharmacologic and psychotherapeutic treatments for panic disorder in the elderly, and to propose a medical treatment algorithm, which should be viewed as a tool that may contribute to the choice of treatment, especially for treatment-resistant older patients with panic disorder. The main results here are the emphasis on antidepressant treatment, like selective serotonin reuptake inhibitor (SSRI), restricted benzodiazepine usage, take care of drug interactions, and importance of psychotherapy like cognitive behavioral therapy (CBT).
引用
收藏
页码:295 / 304
页数:10
相关论文
共 50 条
  • [41] PANIC DISORDER IN PRIMARY CARE
    Cano Vindel, Antonio
    Mae Wood, Cristina
    Dongil, Esperanza
    Miguel Latorre, Jose
    [J]. PAPELES DEL PSICOLOGO, 2011, 32 (03): : 265 - 273
  • [42] Moclobemide and fluoxetine for panic disorder
    Tiller, JWG
    Bouwer, C
    Behnke, K
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1999, 249 (Suppl 1) : S7 - S10
  • [43] Clonazepam for the Treatment of Panic Disorder
    Nardi, Antonio E.
    Machado, Sergio
    Almada, Leonardo Ferreira
    Paes, Flavia
    Silva, Adriana Cardoso
    Marques, Ricardo Jose
    Amrein, Roman
    Freire, Rafael C.
    Martin-Santos, Rocio
    Cosci, Fiammeta
    Hallak, Jaime E.
    Crippa, Jose A.
    Arias-Carrion, Oscar
    [J]. CURRENT DRUG TARGETS, 2013, 14 (03) : 353 - 364
  • [44] Emerging drugs for panic disorder
    Perna, Giampaolo
    Guerriero, Giuseppe
    Caldirola, Daniela
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (04) : 631 - 645
  • [45] Anxiety in middle adulthood: effects of age and time on the 14-year course of panic disorder, social phobia and generalized anxiety disorder
    Ramsawh, H. J.
    Raffa, S. D.
    Edelen, M. Orlando
    Rende, R.
    Keller, M. B.
    [J]. PSYCHOLOGICAL MEDICINE, 2009, 39 (04) : 615 - 624
  • [46] Insomnia Symptoms Following Treatment for Comorbid Panic Disorder With Agoraphobia and Generalized Anxiety Disorder
    Cousineau, Heloise
    Marchand, Andre
    Bouchard, Stephane
    Belanger, Claude
    Gosselin, Patrick
    Langlois, Frederic
    Labrecque, Joane
    Dugas, Michel J.
    Belleville, Genevieve
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 2016, 204 (04) : 267 - 273
  • [47] Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
    Aoki, Akiko
    Ishiguro, Shin
    Watanabe, Takashi
    Ueda, Mikito
    Hayashi, Yuki
    Akiyama, Kazufumi
    Kato, Kazuko
    Inoue, Yoshimasa
    Tsuchimine, Shoko
    Yasui-Furukori, Norio
    Shimoda, Kazutaka
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 1793 - 1798
  • [48] Panic disorder with and without agoraphobia: comorbidity within a half-year of the onset of panic disorder
    Kikuchi, M
    Komuro, R
    Oka, H
    Kidani, T
    Hanaoka, A
    Koshino, Y
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2005, 59 (06) : 639 - 643
  • [49] Onset and temporal sequencing patterns of comorbidity between lifetime major depression, panic disorder and fibromyalgia
    Alciati, A.
    Atzeni, F.
    Salaffi, F.
    Sarzi-Puttini, P.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (06) : 1194 - 1201
  • [50] Personality dimensions in panic disorder and generalized anxiety disorder
    Starcevic, V
    Uhlenhuth, EH
    Fallon, S
    Pathak, D
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 1996, 37 (2-3) : 75 - 79